We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SCHW:NYSECharles Schwab Corporation (The) Analysis

Data as of 2026-05-23 - not real-time

$90.15

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The Charles Schwab Corporation is trading at $90.15, well below its 20‑day SMA of 90.72, 50‑day SMA of 92.65 and 200‑day SMA of 95.40, indicating a short‑term bearish bias. However, the MACD histogram is positive (0.15) and volume is increasing, hinting at emerging momentum. The stock enjoys a solid dividend yield of 1.42% with a modest payout ratio of 22%, supporting income‑focused investors. Fundamentally, SCHW delivers robust profitability—operating margin near 49% and ROE around 19%—and a DCF‑derived fair value of $125, implying roughly 28% upside versus the current price. Recent analyst upgrades, including Barclays raising its target to $127, reinforce the upside narrative, while a few dissenting views keep the consensus at a “Buy.”
Given the low beta (~0.68) and strong cash position, the stock presents a compelling blend of growth and value characteristics, making it attractive for medium‑ to long‑term investors despite the near‑term technical headwinds.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is near the identified support level of $87.61
  • Bearish technical backdrop with price below key SMAs
  • Increasing volume and a positive MACD histogram suggest potential reversal

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value of $125 implies ~28% upside
  • Analyst median price target of $118 and recent target raises
  • Strong revenue growth (15.8%) and high operating margins

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend yield of 1.4% with low payout ratio
  • Robust cash position and low beta reduce market risk
  • Consistent profitability and ROE near 19% support long‑term compounding

Key Metrics & Analysis

Financial Health

Revenue Growth15.80%
Profit Margin37.99%
P/E Ratio17.9
ROE19.08%
ROA1.97%
Debt/Equity120.77
P/B Ratio3.7
Op. Cash Flow$10.3B
Industry P/E16.8

Technical Analysis

TrendBearish
RSI45.9
Support$87.61
Resistance$93.43
MA 20$90.72
MA 50$92.65
MA 200$95.40
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$125.02
Target Price$115.85
Upside/Downside28.51%
GradeUndervalued
TypeBlend
Dividend Yield1.42%

Risk Assessment

Beta0.68
Volatility32.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.